支气管胸膜瘘的危险因素和内科介入治疗进展  

Risk factors and medical interventional therapy progress of bronchopleural fistula

作　　者：邹鑫 张海涛 潘蕾 金发光 李王平 Zou Xin;Zhang Haitao;Pan Lei;Jin Faguang;Li Wangping(Department of Respiratory and Critical Care Medicine,Tangdu Hospital,Air Force Military Medical University,Xi′an 710032,China)

机构地区：[1]空军军医大学唐都医院呼吸与危重症医学科,西安710038

出　　处：《国际呼吸杂志》2024年第6期738-744,共7页International Journal of Respiration

基　　金：陕西省重点研发计划项目(2024SF-YBXM-092);空军军医大学交叉融合专项(2023JC008);空军军医大学2023年临床新技术项目(XJSXYW-2023021)。

摘　　要：支气管胸膜瘘(BPF)是指气管、支气管等气道与胸膜腔形成的病理性窦道,是一种肺切除术后较为严重的并发症,虽然发病率较低,但致死率较高,严重影响了手术后近期疗效。结合近年来国内外对BPF的回顾性研究,本综述总结了BPF的分类与临床表现、危险因素和内科介入治疗进展。目前国际上关于BPF分类主要依据病程、手术后BPF的发生时间;危险因素主要分为手术相关因素和非手术相关因素。治疗进展主要从保守治疗、介入治疗和生物材料等方面进行总结。目前临床上关于BPF治疗方法种类较多,但重点是依据BPF特点针对性选择方案,本综述重点总结了不同治疗方法特点,旨在为临床治疗BPF提供新的思路与选择。Bronchopleural fistula(BPF)is the pathological sinus between airways,including the trachea and bronchus,and the pleural cavity.It is a relatively serious complication after pulmonary resection.Although the incidence is low,the fatality rate is high,which seriously affects the short-term curative effect after surgery.Based on the retrospective studies on BPF at home and abroad in recent years,this review summarizes the classification,clinical manifestations,risk factors,and medical interventional therapy progress of BPF.The international classification of BPF is mainly based on the course of disease and the occurrence time of BPF after surgery.The risk factors are mainly divided into surgery-related factors and non-surgery-related factors.The treatment progress is mainly summarized from the aspects of conservative treatment,interventional therapy,and biomaterials.At present,there are many kinds of treatment methods for BPF in clinical practice,but the focus is to select targeted regimens according to the characteristics of BPF.This review focuses on the characteristics of different treatment methods,so as to provide new ideas and options for the clinical treatment of BPF.

关 键 词：支气管瘘 危险因素 支气管镜检查 

分 类 号：R562[医药卫生—呼吸系统]